Confirmed Speakers
We are excited to welcome the following visionaries, experts and leaders to the GetReal Conference 2024
Blythe Adamson
Head Outcomes Research & Evidence Generation, International / Health & Chair of the Board
Alison Cave
Chief Safety Officer
Stephen Duffield
Associate Director for RWE methods
The National Institute for Health and Care Excellence (NICE)
Guillermo Pérez García
HTA Analyst
HTA Unit, Institute for Health Sciences of Aragon (IACS)
Wim Goettsch
Professor HTA of Pharmaceuticals, WHO Collaborating Centre for Pharmaceutical Policy and Regulation; Division of Pharmacoepidemiology & Clinical Pharmacology
Utrecht University
Manuel Gomes
Professor of Health Economics
UCL
Marcus Guardian
Partner
Dierks+Company
Former EUnetHTA
Iñaki Gutiérrez-Ibarluzea
Head of Knowledge Management and Evaluation
Basque Foundation for Health Innovation and Research (BIOEF)
Shahid Hanif
Managing Director
GetReal Institute
Niklas Hedberg
Chief Pharmacist
TLV
Inka Heikkinen
Director Global Regulatory Policy
MSD / EFPIA
Farah Husein
Director, Science and Methods
Canada’s Drug Agency
Irene Nunes
Senior Vice-President, Global Head of Regulatory Affairs
Genmab
Juan Carlos Rejón Parrilla
HTA Researcher
Andalusian Health Technology Assessment Unit (AETSA)
Elena Petelos
Public Health Specialist & HTA Expert
University of Crete/Maastricht, EUPHA, HTAi RWE & AI IGC
Katrien Oude Rengerink
Methodology Assessor
CBG-MEB
Donna Rivera
Associate Director of Pharmacoepidemiology | RWD & RWE
FDA Oncology Center of Excellence
Bettina Ryll
Founder
Melanoma Patient Network Europe
Delphine Saragoussi
Executive Director, Epidemiology & Scientific Affairs
Evidera / ISPE RWE Collaborative SIG
Anja Schiel
Statistician & Methodologist
The Norwegian Medicines Agency (NOMA)
Álmath Spooner
Head of Europe Regulatory Policy
AbbVie
Anna Steenrod
Senior Director, Population Health Insights and Impact
Roche
Miriam Sturkenboom
President
VACE4EU
Anke van Engen
Managing Principal, Value and Payer Evidence
IQVIA
Patrice Verpillat
Head Of The Real World Evidence (RWE) Workstream
European Medicines Agency
Elizabeth Vroom
Chair
World Duchenne Organisation
Silvia Moler Zapata
HTA Analyst
HTA Unit, Institute for Health Sciences of Aragon (IACS)
